Home » CLINICAL STUDY EVALUATING TREATMENT OF DIABETIC FOOT ULCERS USING MICROCYN TECHNOLOGY PRESENTED AT STUTTGART2005
CLINICAL STUDY EVALUATING TREATMENT OF DIABETIC FOOT ULCERS USING MICROCYN TECHNOLOGY PRESENTED AT STUTTGART2005
Oculus Innovative Sciences announced that Luca Dalla Paola, a surgeon with the
diabetic foot unit of the Abano Terme Hospital in Italy, recently presented
the results of a 218-patient controlled clinical study that assessed the safety
and efficacy of Microcyn Technology in treating diabetic foot ulcers as compared
to povidone iodine (10%) antiseptic, which is often used as the "standard
care" in treatment of open wounds.
Yahoo
News
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May